Genome-wide copy number variation study associates metabotropic glutamate receptor gene networks with attention deficit hyperactivity disorder.
- Authors
- Elia, Josephine; Glessner, Joseph T; Wang, Kai; Takahashi, Nagahide; Shtir, Corina J; Hadley, Dexter; Sleiman, Patrick M A; Zhang, Haitao; Kim, Cecilia E; Robison, Reid; Lyon, Gholson J; Flory, James H; Bradfield, Jonathan P; Imielinski, Marcin; Hou, Cuiping; Frackelton, Edward C; Chiavacci, Rosetta M; Sakurai, Takeshi; Rabin, Cara; Middleton, Frank A; Thomas, Kelly A; Garris, Maria; Mentch, Frank; Freitag, Christine M; Steinhausen, Hans-Christoph; Todorov, Alexandre A; Reif, Andreas; Rothenberger, Aribert; Franke, Barbara; Mick, Eric O; Roeyers, Herbert; Buitelaar, Jan; Lesch, Klaus-Peter; Banaschewski, Tobias; Ebstein, Richard P; Mulas, Fernando; Oades, Robert D; Sergeant, Joseph; Sonuga-Barke, Edmund; Renner, Tobias J; Romanos, Marcel; Romanos, Jasmin; Warnke, Andreas; Walitza, Susanne; Meyer, Jobst; PΓ‘lmason, Haukur; Seitz, Christiane; Loo, Sandra K; Smalley, Susan L; Biederman, Joseph; Kent, Lindsey; Asherson, Philip; Anney, Richard J L; Gaynor, J William; Shaw, Philip; Devoto, Marcella; White, Peter S; Grant, Struan F A; Buxbaum, Joseph D; Rapoport, Judith L; Williams, Nigel M; Nelson, Stanley F; Faraone, Stephen V; Hakonarson, Hakon
- Year
- 2011
- Journal
- Nature genetics
- PMID
- 22138692
- DOI
- 10.1038/ng.1013
- PMCID
- PMC4310555
Attention deficit hyperactivity disorder (ADHD) is a common, heritable neuropsychiatric disorder of unknown etiology. We performed a whole-genome copy number variation (CNV) study on 1,013 cases with ADHD and 4,105 healthy children of European ancestry using 550,000 SNPs. We evaluated statistically significant findings in multiple independent cohorts, with a total of 2,493 cases with ADHD and 9,222 controls of European ancestry, using matched platforms. CNVs affecting metabotropic glutamate receptor genes were enriched across all cohorts (P = 2.1 Γ 10(-9)). We saw GRM5 (encoding glutamate receptor, metabotropic 5) deletions in ten cases and one control (P = 1.36 Γ 10(-6)). We saw GRM7 deletions in six cases, and we saw GRM8 deletions in eight cases and no controls. GRM1 was duplicated in eight cases. We experimentally validated the observed variants using quantitative RT-PCR. A gene network analysis showed that genes interacting with the genes in the GRM family are enriched for CNVs in βΌ10% of the cases (P = 4.38 Γ 10(-10)) after correction for occurrence in the controls. We identified rare recurrent CNVs affecting glutamatergic neurotransmission genes that were overrepresented in multiple ADHD cohorts.
A deletion directly affecting GRM5 that is exclusive to cases with ADHD and that was replicated in the IMAGE and PUWMa studies. Four hemizygous deletions in GRM5 in cases with ADHD from the CHOP study that were replicated by two deletions and three larger deletions found in the IMAGE study and one deletion found in the PUWMa study. The SNP coverage of the Illumina 550K, Perlegen 600K, Illumina 1M and Affymetrix 5.0 arrays is shown by vertical blue lines. M.Of.M.Cs., Massachusetts General Hospital offspring male case; W.Fa.M.Cn., Washington University father male control.
GRM receptor gene interaction networks affected in ADHD. (a) GRM receptor genes are shown as large diamond-shaped nodes, and other genes within two degrees of interaction with GRM genes are shown as smaller circular nodes. Nodes are colored to represent the enrichment of the CNVs: dark red represents deletions enriched in cases, light red represents deletions enriched in controls, dark turquoise represents duplications enriched in cases, light turquoise represents duplications enriched in controls, and gray represents diploids that are devoid of CNVs. Thick blue dashed lines highlight edges that are connected to at least one GRM gene, and thin gray lines represent all other gene interactions. Highly connected modules enriched for significant functional annotations are highlighted by blue shaded ellipses. Details on the gene-based CNV observations are included in Supplementary Table 16, and the respective gene functional clusters are listed in Supplementary Table 17. (b) A schematic overview showing the interaction of GRM receptors affected in ADHD with modules of genes enriched for functional significance. GRM receptor genes are shown as diamonds colored either turquoise or red to represent duplications and deletions, respectively, that were enriched in cases. Boxes highlight the functional modules defined by the network of interacting genes (a) that are significantly enriched for Gene Ontology annotations. The functional modules describe significant functional annotations and are labeled with the cluster name and the number of component genes in parenthesis. Functional annotations that may be particularly pertinent to the underlying pathophysiology of ADHD are shown in bold. The edges of the network connect GRM receptor genes to functional modules: solid lines indicate membership of the GRM-interacting gene in the functional module, and dotted lines indicate a first-degree relationship between GRM receptor genes and at least one component gene of a functional module
No entities extracted from this document yet.
No uploaded files.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Animal models of attention-deficit/hyperactivity disorder: Diversity and validity. | Sarah BSN et al. | β | 2026 | β |
| Developmental trajectories of glutamate and the variable clinical course of ADHD in youth. | Bouyssi-Kobar M et al. | β | 2026 | β |
| Metabotropic glutamate receptor 5 in the anterior cingulate cortex predicts individual differences in motor impulsivity but not in risky decision-making. | Marchessaux F et al. | β | 2026 | β |
| The Impact of 8p23 Copy Number Variations on Neurodevelopmental Aetiology: A Focus on Rare Deletions. | GΓΌleΓ§ A et al. | β | 2026 | β |
| Current Perspectives on Attention-deficit Hyperactivity Disorder. | Shafiullah S et al. | β | 2025 | β |
| GPCR-G protein signalling and its mutational landscape in cancer-Driver or passenger. | Feng C et al. | β | 2025 | β |
| GPCRs in CAR-T Cell Immunotherapy: Expanding the Target Landscape and Enhancing Therapeutic Efficacy. | Liu Z et al. | β | 2025 | β |
| Identification of a Novel GRM1 Frameshift Variant in Two Pakistani Families Broadens the Genetic Landscape of Ultra-Rare Spinocerebellar Ataxia Type 13. | Ahmad R et al. | β | 2025 | β |
| Implications of childhood subcortical volumes on psychiatric disorders: A mendelian randomization study. | Ran Q et al. | β | 2025 | β |
| Motor learning is regulated by postnatal GDNF levels in Purkinje cells. | Nagaeva E et al. | β | 2025 | β |
| Neural excitation/inhibition imbalance and neurodevelopmental pathology in human copy number variant syndromes: a systematic review. | Sylvester AL et al. | β | 2025 | β |
| Overexpression of mGlu<sub>7B</sub> in Mice: Implications for Neurodevelopmental Disorders. | Freitas GA et al. | β | 2025 | β |
| Profiling the Impact of mGlu<sub>7</sub>/Elfn1 Protein Interactions on the Pharmacology of mGlu<sub>7</sub> Allosteric Modulators. | Lei X et al. | β | 2025 | β |
| Spina bifida, diplomyelia, and Chiari-like malformation in an Aberdeen Angus calf. | Korte A et al. | β | 2025 | β |
| Unraveling Attention-Deficit/Hyperactivity Disorder Etiology: Current Challenges and Future Directions in Treatment. | Poddar A et al. | β | 2025 | β |
| Cortico-striatal differences in the epigenome in attention-deficit/ hyperactivity disorder. | Shastri GG et al. | β | 2024 | β |
| GRM7 deficiency, from excitotoxicity and neuroinflammation to neurodegeneration: Systematic review of GRM7 deficient patients. | Zaki-Dizaji M et al. | β | 2024 | β |
| New Advances in Attention-Deficit/Hyperactivity Disorder-like Dogs. | GonzΓ‘lez-MartΓnez Γ et al. | β | 2024 | β |
| Novel pharmacological targets for GABAergic dysfunction in ADHD. | Ferranti AS et al. | β | 2024 | β |
| Simultaneous de novo calling and phasing of genetic variants at chromosome-scale using NanoStrand-seq. | Bai X et al. | β | 2024 | β |
| Therapeutic Potential for Metabotropic Glutamate Receptor 7 Modulators in Cognitive Disorders. | Parent HH et al. | β | 2024 | β |
| The Traf2 and NcK interacting kinase inhibitor NCB-0846 suppresses seizure activity involving the decrease of GRIA1. | Wang M et al. | β | 2024 | β |
| VISTA: an integrated framework for structural variant discovery. | Sarwal V et al. | β | 2024 | β |
| Genetic Variant in <i>GRM1</i> Underlies Congenital Cerebellar Ataxia with No Obvious Intellectual Disability. | Protasova MS et al. | β | 2023 | β |
| Glutamate receptor genetic variants affected peripheral glutamatergic transmission and treatment induced improvement of Indian ADHD probands. | Chatterjee M et al. | β | 2023 | β |
| GRM7 gene mutations and consequences for neurodevelopment. | Freitas GA et al. | β | 2023 | β |
| Mapping the cortico-striatal transcriptome in attention deficit hyperactivity disorder. | Sudre G et al. | β | 2023 | β |
| Molecular Mechanisms Underlying NMDARs Dysfunction and Their Role in ADHD Pathogenesis. | KuΕ J et al. | β | 2023 | β |
| Neuroimaging genetics approaches to identify new biomarkers for the early diagnosis of autism spectrum disorder. | Nisar S et al. | β | 2023 | β |
| ParseCNV2: efficient sequencing tool for copy number variation genome-wide association studies. | Glessner JT et al. | β | 2023 | β |
| Persistent challenges in the development of an mGlu<sub>7</sub> PAM in vivo tool compound: The discovery of VU6046980. | Kalbfleisch JJ et al. | β | 2023 | β |
| Rare copy number variants in males and females with childhood attention-deficit/hyperactivity disorder. | Jung B et al. | β | 2023 | β |
| Rare recurrent copy number variations in metabotropic glutamate receptor interacting genes in children with neurodevelopmental disorders. | Glessner JT et al. | β | 2023 | β |
| The Role of Hedgehog Signaling in the Melanoma Tumor Bone Microenvironment | Shamsoon K et al. | β | 2023 | β |
| The Role of Hedgehog Signaling in the Melanoma Tumor Bone Microenvironment. | Shamsoon K et al. | β | 2023 | β |
| A comprehensive benchmarking of WGS-based deletion structural variant callers. | Sarwal V et al. | β | 2022 | β |
| An electronic health record (EHR) phenotype algorithm to identify patients with attention deficit hyperactivity disorders (ADHD) and psychiatric comorbidities. | Slaby I et al. | β | 2022 | β |
| Attention-deficit/hyperactive disorder updates. | Kessi M et al. | β | 2022 | β |
| Chromosomal microarray analysis of 410 Han Chinese patients with autism spectrum disorder or unexplained intellectual disability and developmental delay. | Liu Y et al. | β | 2022 | β |
| Correlation research of susceptibility single nucleotide polymorphisms and the severity of clinical symptoms in attention deficit hyperactivity disorder. | Xu Y et al. | β | 2022 | β |
| Elevated endogenous GDNF induces altered dopamine signalling in mice and correlates with clinical severity in schizophrenia. | MΓ€tlik K et al. | β | 2022 | β |
| Epigenetics and first-episode psychosis: A systematic review. | Lockwood L et al. | β | 2022 | β |
| Group 1 Metabotropic Glutamate Receptors in Neurological and Psychiatric Diseases: Mechanisms and Prospective. | Su LD et al. | β | 2022 | β |
| Loss-of-Function Models of the Metabotropic Glutamate Receptor Genes <i>Grm8a</i> and <i>Grm8b</i> Display Distinct Behavioral Phenotypes in Zebrafish Larvae (<i>Danio rerio</i>). | LΓΌffe TM et al. | β | 2022 | β |
| Molecular Characterisation of the Mechanism of Action of Stimulant Drugs Lisdexamfetamine and Methylphenidate on ADHD Neurobiology: A Review. | Quintero J et al. | β | 2022 | β |
| Neuromorphological and Neurofunctional Correlates of ADHD and ADD in the Auditory Cortex of Adults. | Serrallach BL et al. | β | 2022 | β |
| Potential Inflammatory Biomarker in Patients with Attention Deficit Hyperactivity Disorder. | Park JH | β | 2022 | β |
| Research models of neurodevelopmental disorders: The right model in the right place. | Damianidou E et al. | β | 2022 | β |
| The electroretinogram b-wave amplitude: a differential physiological measure for Attention Deficit Hyperactivity Disorder and Autism Spectrum Disorder. | Lee IO et al. | β | 2022 | β |
| The Evaluation of Genetic Diagnosis on High-Risk Fetal CAKUT. | Liu W et al. | β | 2022 | β |
| Treatment biomarkers for ADHD: Taking stock and moving forward. | Michelini G et al. | β | 2022 | β |
| Adolescent Attention-Deficit/Hyperactivity Disorder: Understanding Teenage Symptom Trajectories. | Shaw P et al. | β | 2021 | β |
| A GRM7 mutation associated with developmental delay reduces mGlu7 expression and produces neurological phenotypes. | Fisher NM et al. | β | 2021 | β |
| Alcohol use disorders and ADHD. | Luderer M et al. | β | 2021 | β |
| An epigenetic, transgenerational model of increased mental health disorders in children, adolescents and young adults. | Monaco AP | β | 2021 | β |
| An Insight into GPCR and G-Proteins as Cancer Drivers. | Chaudhary PK et al. | β | 2021 | β |
| Association between the group III metabotropic glutamate receptor gene polymorphisms and attention-deficit/hyperactivity disorder and functional exploration of risk loci. | Zhang Q et al. | β | 2021 | β |
| Deep learning prediction of attention-deficit hyperactivity disorder in African Americans by copy number variation. | Liu Y et al. | β | 2021 | β |
| Detection of copy number variation associated with ventriculomegaly in fetuses using single nucleotide polymorphism arrays. | Xue H et al. | β | 2021 | β |
| Mutations in G Protein-Coupled Receptors: Mechanisms, Pathophysiology and Potential Therapeutic Approaches. | SchΓΆneberg T et al. | β | 2021 | β |
| Pathogenic <i>GRM7</i> Mutations Associated with Neurodevelopmental Disorders Impair Axon Outgrowth and Presynaptic Terminal Development. | Song JM et al. | β | 2021 | β |
| Peripheral biomarkers of attention-deficit hyperactivity disorder: Current status and future perspective. | Takahashi N et al. | β | 2021 | β |
| Rare Recurrent Variants in Noncoding Regions Impact Attention-Deficit Hyperactivity Disorder (ADHD) Gene Networks in Children of both African American and European American Ancestry. | Liu Y et al. | β | 2021 | β |
| Trans-Synaptic Regulation of Metabotropic Glutamate Receptors by Elfn Proteins in Health and Disease. | Matsunaga H et al. | β | 2021 | β |
| Appropriateness of array-CGH in the ADHD clinics: A comparative study. | Baccarin M et al. | β | 2020 | β |
| Attention-deficit hyperactivity disorder. | Posner J et al. | β | 2020 | β |
| Biallelic GRM7 variants cause epilepsy, microcephaly, and cerebral atrophy. | Marafi D et al. | β | 2020 | β |
| Detection of copy number disorders associated with congenital anomalies of the kidney and urinary tract in fetuses via single nucleotide polymorphism arrays. | Cai M et al. | β | 2020 | β |
| Discovery of VU6027459: A First-in-Class Selective and CNS Penetrant mGlu<sub>7</sub> Positive Allosteric Modulator Tool Compound. | Reed CW et al. | β | 2020 | β |
| Energy Metabolism Disturbances in Cell Models of PARK2 CNV Carriers with ADHD. | Palladino VS et al. | β | 2020 | β |
| From man to fly - convergent evidence links FBXO25 to ADHD and comorbid psychiatric phenotypes. | Harich B et al. | β | 2020 | β |
| Genetic characterization of HIV-1 epidemic in Anhui Province, China. | Zhang D et al. | β | 2020 | β |
| Genetics of ADHD: What Should the Clinician Know? | Grimm O et al. | β | 2020 | β |
| Impulsivity is a heritable trait in rodents and associated with a novel quantitative trait locus on chromosome 1. | Jupp B et al. | β | 2020 | β |
| Intragenic CNTN4 copy number variants associated with a spectrum of neurobehavioral phenotypes. | Zhang SQ et al. | β | 2020 | β |
| Mental health dished up-the use of iPSC models in neuropsychiatric research. | McNeill RV et al. | β | 2020 | β |
| mGlu5 in GABAergic neurons modulates spontaneous and psychostimulant-induced locomotor activity. | Wu CS et al. | β | 2020 | β |
| Mitochondrial DNA haplogroups and risk of attention deficit and hyperactivity disorder in European Americans. | Chang X et al. | β | 2020 | β |
| Neurochemical Correlates of Executive Function in Children with Attention-Deficit/Hyperactivity Disorder. | Hai T et al. | β | 2020 | β |
| Non-coding structural variation differentially impacts attention-deficit hyperactivity disorder (ADHD) gene networks in African American vs Caucasian children. | Liu Y et al. | β | 2020 | β |
| Phenotypic profiling of mGlu<sub>7</sub> knockout mice reveals new implications for neurodevelopmental disorders. | Fisher NM et al. | β | 2020 | β |
| The fine-scale genetic structure and selection signals of Chinese indigenous pigs. | Huang M et al. | β | 2020 | β |
| ADGRL3 rs6551665 as a Common Vulnerability Factor Underlying Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorder. | Kappel DB et al. | β | 2019 | β |
| Adult onset of type 3 deiodinase deficiency in mice alters brain gene expression and increases locomotor activity. | Stohn JP et al. | β | 2019 | β |
| Atomoxetine produces oxidative stress and alters mitochondrial function in human neuron-like cells. | Corona JC et al. | β | 2019 | β |
| Autism-related behaviors in the cyclooxygenase-2-deficient mouse model. | Wong CT et al. | β | 2019 | β |
| Basolateral amygdala, nicotinic cholinergic receptors, and nicotine: Pharmacological effects and addiction in animal models and humans. | Sharp BM | β | 2019 | β |
| Cross-species models of attention-deficit/hyperactivity disorder and autism spectrum disorder: lessons from CNTNAP2, ADGRL3, and PARK2. | Dalla Vecchia E et al. | β | 2019 | β |
| Does Prenatal Stress Shape Postnatal Resilience? - An Epigenome-Wide Study on Violence and Mental Health in Humans. | Serpeloni F et al. | β | 2019 | β |
| Genetic Associations between Voltage-Gated Calcium Channels and Psychiatric Disorders. | Andrade A et al. | β | 2019 | β |
| Genetics of attention deficit hyperactivity disorder. | Faraone SV et al. | β | 2019 | β |
| Glutamate receptor metabotropic 7 (GRM7) gene polymorphisms in mood disorders and attention deficit hyperactive disorder. | Noroozi R et al. | β | 2019 | β |
| Impact of autism-associated genetic variants in interaction with environmental factors on ADHD comorbidities: an exploratory pilot study. | Waltes R et al. | β | 2019 | β |
| Lrrc7 mutant mice model developmental emotional dysregulation that can be alleviated by mGluR5 allosteric modulation. | Chong CH et al. | β | 2019 | β |
| Maternal immune activation impairs cognitive flexibility and alters transcription in frontal cortex. | Amodeo DA et al. | β | 2019 | β |
| Modeling and Predicting Developmental Trajectories of Neuropsychiatric Dimensions Associated With Copy Number Variations. | Hiroi N et al. | β | 2019 | β |
| The role of GPCRs in bone diseases and dysfunctions. | Luo J et al. | β | 2019 | β |
| Updated European Consensus Statement on diagnosis and treatment of adult ADHD. | Kooij JJS et al. | β | 2019 | β |
| Anterior cingulate cortex glutamate and its association with striatal functioning during cognitive control. | Naaijen J et al. | β | 2018 | β |
| Attention deficit/hyperactivity-disorder and obesity: A review and model of current hypotheses explaining their comorbidity. | HanΔ T et al. | β | 2018 | β |
| Discoveries on the Genetics of ADHD in the 21st Century: New Findings and Their Implications. | Thapar A | β | 2018 | β |
| Fasoracetam in adolescents with ADHD and glutamatergic gene network variants disrupting mGluR neurotransmitter signaling. | Elia J et al. | β | 2018 | β |
| [Genetics and epigenetics of attention deficit hyperactivity disorder]. | Mustafin RN et al. | β | 2018 | β |
| Genome-wide association study identifies <i>RBFOX1</i> locus influencing brain glucose metabolism. | Kong LL et al. | β | 2018 | β |
| Glutamatergic synapses in neurodevelopmental disorders. | Moretto E et al. | β | 2018 | β |
| Identification of Copy Number Variants from SNP Arrays Using PennCNV. | Fang L et al. | β | 2018 | β |
| Identifying disease-associated copy number variations by a doubly penalized regression model. | Cheng Y et al. | β | 2018 | β |
| Integrative genomic analysis of methylphenidate response in attention-deficit/hyperactivity disorder. | Pagerols M et al. | β | 2018 | β |
| l-Carnosine as Adjunctive Therapy in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial. | Ghajar A et al. | β | 2018 | β |
| Metabotropic Glutamate Receptor 7: A New Therapeutic Target in Neurodevelopmental Disorders. | Fisher NM et al. | β | 2018 | β |
| Neural stem cells in neuropsychiatric disorders. | Sacco R et al. | β | 2018 | β |
| Neuroanatomic, epigenetic and genetic differences in monozygotic twins discordant for attention deficit hyperactivity disorder. | Chen YC et al. | β | 2018 | β |
| Next-generation sequencing in drug development: target identification and genetically stratified clinical trials. | Doostparast Torshizi A et al. | β | 2018 | β |
| Predicting attention deficit hyperactivity disorder using pregnancy and birth characteristics. | Schwenke E et al. | β | 2018 | β |
| Prefrontal cortex executive processes affected by stress in health and disease. | Girotti M et al. | β | 2018 | β |
| QuilliChew extended-release chewable tablets for the treatment of ADHD in patients ages 6 years old and above. | Childress A et al. | β | 2018 | β |
| Recent developments in the genetics of attention-deficit hyperactivity disorder. | Grimm O et al. | β | 2018 | β |
| Sex Differences in Psychiatric Disease: A Focus on the Glutamate System. | Wickens MM et al. | β | 2018 | β |
| The impact of epigenomic next-generation sequencing approaches on our understanding of neuropsychiatric disorders. | Schang AL et al. | β | 2018 | β |
| The pharmacology of amphetamine and methylphenidate: Relevance to the neurobiology of attention-deficit/hyperactivity disorder and other psychiatric comorbidities. | Faraone SV | β | 2018 | β |
| The role of ADHD associated genes in neurodevelopment. | Dark C et al. | β | 2018 | β |
| A 7q31.33q32.1 microdeletion including <i>LRRC4</i> and <i>GRM8</i> is associated with severe intellectual disability and characteristics of autism. | Sangu N et al. | β | 2017 | β |
| A current view on contactin-4, -5, and -6: Implications in neurodevelopmental disorders. | Oguro-Ando A et al. | β | 2017 | β |
| Attention-Deficit/Hyperactivity Disorder. | Banaschewski T et al. | β | 2017 | β |
| Basolateral amygdala and stress-induced hyperexcitability affect motivated behaviors and addiction. | Sharp BM | β | 2017 | β |
| Brain imaging genetics in ADHD and beyond - Mapping pathways from gene to disorder at different levels of complexity. | Klein M et al. | β | 2017 | β |
| Clinical relevance of small copy-number variants in chromosomal microarray clinical testing. | Hollenbeck D et al. | β | 2017 | β |
| Copy number variation meta-analysis reveals a novel duplication at 9p24 associated with multiple neurodevelopmental disorders. | Glessner JT et al. | β | 2017 | β |
| Discovery of VU6005649, a CNS Penetrant mGlu<sub>7/8</sub> Receptor PAM Derived from a Series of Pyrazolo[1,5-<i>a</i>]pyrimidines. | Abe M et al. | β | 2017 | β |
| Fifty Years of Research in ARDS. Genomic Contributions and Opportunities. | Reilly JP et al. | β | 2017 | β |
| Genetic Approaches to Understanding Psychiatric Disease. | Michaelson JJ | β | 2017 | β |
| Genomic Disorders in Psychiatry-What Does the Clinician Need to Know? | Lowther C et al. | β | 2017 | β |
| Glutamatergic and GABAergic gene sets in attention-deficit/hyperactivity disorder: association to overlapping traits in ADHD and autism. | Naaijen J et al. | β | 2017 | β |
| High resolution chromosomal microarray analysis in paediatric obsessive-compulsive disorder. | GrΓΌnblatt E et al. | β | 2017 | β |
| Long-term prenatal exposure to paracetamol is associated with DNA methylation differences in children diagnosed with ADHD. | Gervin K et al. | β | 2017 | β |
| Precision annotation of digital samples in NCBI's gene expression omnibus. | Hadley D et al. | β | 2017 | β |
| Rare copy number variants in patients with congenital conotruncal heart defects. | Xie HM et al. | β | 2017 | β |
| Rare DNA variants in the brain-derived neurotrophic factor gene increase risk for attention-deficit hyperactivity disorder: a next-generation sequencing study. | Hawi Z et al. | β | 2017 | β |
| Shared genetic influences between dimensional ASD and ADHD symptoms during child and adolescent development. | Stergiakouli E et al. | β | 2017 | β |
| Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders. | Li J et al. | β | 2017 | β |
| The Effect of Experimental Supplementation with the Klamath Algae Extract Klamin on Attention-Deficit/Hyperactivity Disorder. | Cremonte M et al. | β | 2017 | β |
| The use of modified-release methylphenidate in the treatment of attention-deficit/hyperactivity disorder. | Childress A et al. | β | 2017 | β |
| A current snapshot of common genomic variants contribution in psychiatric disorders. | Santoro ML et al. | β | 2016 | β |
| An integrative approach to investigate the respective roles of single-nucleotide variants and copy-number variants in Attention-Deficit/Hyperactivity Disorder. | Lima Lde A et al. | β | 2016 | β |
| A null mutation in TNIK defines a novel locus for intellectual disability. | Anazi S et al. | β | 2016 | β |
| Association of AADAC Deletion and Gilles de la Tourette Syndrome in a Large European Cohort. | Bertelsen B et al. | β | 2016 | β |
| CNV analysis in Chinese children of mental retardation highlights a sex differentiation in parental contribution to de novo and inherited mutational burdens. | Wang B et al. | β | 2016 | β |
| Comparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone Acetonide. | Smit-McBride Z et al. | β | 2016 | β |
| Copy-number variations are enriched for neurodevelopmental genes in children with developmental coordination disorder. | Mosca SJ et al. | β | 2016 | β |
| Decoding the non-coding genome: elucidating genetic risk outside the coding genome. | Barr CL et al. | β | 2016 | β |
| Genetics of attention-deficit/hyperactivity disorder: an update. | Akutagava-Martins GC et al. | β | 2016 | β |
| Glutamate receptor, metabotropic 7 (GRM7) gene variations and susceptibility to autism: A case-control study. | Noroozi R et al. | β | 2016 | β |
| G protein-coupled receptors as promising cancer targets. | Liu Y et al. | β | 2016 | β |
| Investigating the effects of copy number variants on reading and language performance. | Gialluisi A et al. | β | 2016 | β |
| Machine learning derived risk prediction of anorexia nervosa. | Guo Y et al. | β | 2016 | β |
| Maternal plasma folate impacts differential DNA methylation in an epigenome-wide meta-analysis of newborns. | Joubert BR et al. | β | 2016 | β |
| Methylphenidate HCL for the treatment of ADHD in children and adolescents. | Childress AC | β | 2016 | β |
| Moving towards causality in attention-deficit hyperactivity disorder: overview of neural and genetic mechanisms. | Gallo EF et al. | β | 2016 | β |
| Novel Insights into NeuN: from Neuronal Marker to Splicing Regulator. | Duan W et al. | β | 2016 | β |
| Pre- and Perinatal Ischemia-Hypoxia, the Ischemia-Hypoxia Response Pathway, and ADHD Risk. | Smith TF et al. | β | 2016 | β |
| Psychiatric gene discoveries shape evidence on ADHD's biology. | Thapar A et al. | β | 2016 | β |
| Test for association of common variants in GRM7 with alcohol consumption. | Melroy-Greif WE et al. | β | 2016 | β |
| Xp11.2 microduplications including IQSEC2, TSPYL2 and KDM5C genes in patients with neurodevelopmental disorders. | Moey C et al. | β | 2016 | β |
| ADHD & Pharmacotherapy: Past, Present and Future: A Review of the Changing Landscape of Drug Therapy for Attention Deficit Hyperactivity Disorder. | Connolly JJ et al. | β | 2015 | β |
| Annual research review: Rare genotypes and childhood psychopathology--uncovering diverse developmental mechanisms of ADHD risk. | Scerif G et al. | β | 2015 | β |
| A selective review of glutamate pharmacological therapy in obsessive-compulsive and related disorders. | Grados MA et al. | β | 2015 | β |
| Association study of GRM7 polymorphisms and schizophrenia in the Chinese Han population. | Niu W et al. | β | 2015 | β |
| Attention-deficit/hyperactivity disorder. | Faraone SV et al. | β | 2015 | β |
| Burden analysis of rare microdeletions suggests a strong impact of neurodevelopmental genes in genetic generalised epilepsies. | Lal D et al. | β | 2015 | β |
| Clinically relevant copy number variations detected in cerebral palsy. | Oskoui M et al. | β | 2015 | β |
| ClusterViz: A Cytoscape APP for Cluster Analysis of Biological Network. | Wang J et al. | β | 2015 | β |
| Detection and correction of artefacts in estimation of rare copy number variants and analysis of rare deletions in type 1 diabetes. | Cooper NJ et al. | β | 2015 | β |
| Duplications in ADHD patients harbour neurobehavioural genes that are co-expressed with genes associated with hyperactivity in the mouse. | Taylor A et al. | β | 2015 | β |
| GABAA overactivation potentiates the effects of NMDA blockade during the brain growth spurt in eliciting locomotor hyperactivity in juvenile mice. | Oliveira-Pinto J et al. | β | 2015 | β |
| Genetics in child and adolescent psychiatry: methodological advances and conceptual issues. | Hohmann S et al. | β | 2015 | β |
| Genome-wide copy-number variation study of psychosis in Alzheimer's disease. | Zheng X et al. | β | 2015 | β |
| GRM7 regulates embryonic neurogenesis via CREB and YAP. | Xia W et al. | β | 2015 | β |
| Modeling a model: Mouse genetics, 22q11.2 Deletion Syndrome, and disorders of cortical circuit development. | Meechan DW et al. | β | 2015 | β |
| New genes for focal epilepsies with speech and language disorders. | Turner SJ et al. | β | 2015 | β |
| Organization of TNIK in dendritic spines. | Burette AC et al. | β | 2015 | β |
| Rare de novo deletion of metabotropic glutamate receptor 7 (GRM7) gene in a patient with autism spectrum disorder. | Liu Y et al. | β | 2015 | β |
| Schizophrenia genetics: emerging themes for a complex disorder. | Kavanagh DH et al. | β | 2015 | β |
| Simplex and multiplex stratification in ASD and ADHD families: a promising approach for identifying overlapping and unique underpinnings of ASD and ADHD? | Oerlemans AM et al. | β | 2015 | β |
| The molecular genetic architecture of attention deficit hyperactivity disorder. | Hawi Z et al. | β | 2015 | β |
| Unmet needs in paediatric psychopharmacology: Present scenario and future perspectives. | Persico AM et al. | β | 2015 | β |
| Absent CNKSR2 causes seizures and intellectual, attention, and language deficits. | Vaags AK et al. | β | 2014 | β |
| A case of 17q21.31 microduplication and 7q31.33 microdeletion, associated with developmental delay, microcephaly, and mild dysmorphic features. | Mc Cormack A et al. | β | 2014 | β |
| Allelic association, DNA resequencing and copy number variation at the metabotropic glutamate receptor GRM7 gene locus in bipolar disorder. | Kandaswamy R et al. | β | 2014 | β |
| Analysis of chromosomal structural variation in patients with congenital left-sided cardiac lesions. | White PS et al. | β | 2014 | β |
| Cntnap4 differentially contributes to GABAergic and dopaminergic synaptic transmission. | Karayannis T et al. | β | 2014 | β |
| Copy number variation analysis in the context of electronic medical records and large-scale genomics consortium efforts. | Connolly JJ et al. | β | 2014 | β |
| Evidence-based guidelines for the pharmacological management of attention deficit hyperactivity disorder: update on recommendations from the British Association for Psychopharmacology. | Bolea-AlamaΓ±ac B et al. | β | 2014 | β |
| Functional gene-set analysis does not support a major role for synaptic function in attention deficit/hyperactivity disorder (ADHD). | Hammerschlag AR et al. | β | 2014 | β |
| Genetic influences on alcohol use across stages of development: GABRA2 and longitudinal trajectories of drunkenness from adolescence to young adulthood. | Dick DM et al. | β | 2014 | β |
| Genome-wide analysis of rare copy number variations reveals PARK2 as a candidate gene for attention-deficit/hyperactivity disorder. | Jarick I et al. | β | 2014 | β |
| Glutamate/glutamine and neuronal integrity in adults with ADHD: a proton MRS study. | Maltezos S et al. | β | 2014 | β |
| Glutamate receptor mutations in psychiatric and neurodevelopmental disorders. | Soto D et al. | β | 2014 | β |
| Glutamatergic copy number variants and their role in attention-deficit/hyperactivity disorder. | Akutagava-Martins GC et al. | β | 2014 | β |
| Identification of novel GRM1 mutations and single nucleotide polymorphisms in prostate cancer cell lines and tissues. | Ali S et al. | β | 2014 | β |
| Identification of structural variation in mouse genomes. | Keane TM et al. | β | 2014 | β |
| Molecular genetic studies of ADHD and its candidate genes: a review. | Li Z et al. | β | 2014 | β |
| The impact of the metabotropic glutamate receptor and other gene family interaction networks on autism. | Hadley D et al. | β | 2014 | β |
| Altered gene expression in the prefrontal cortex of young rats induced by the ADHD drug atomoxetine. | Lempp T et al. | β | 2013 | β |
| Ask the experts: pharmacogenomics and genome-wide association studies. | Hakonarson H | β | 2013 | β |
| Association between the GRM7 rs3792452 polymorphism and attention deficit hyperacitiveity disorder in a Korean sample. | Park S et al. | β | 2013 | β |
| Background, clinical features and treatment of attention deficit hyperactivity disorder in children. | Warikoo N et al. | β | 2013 | β |
| Candidate genetic pathways for attention-deficit/hyperactivity disorder (ADHD) show association to hyperactive/impulsive symptoms in children with ADHD. | Bralten J et al. | β | 2013 | β |
| Child development and structural variation in the human genome. | Zhang Y et al. | β | 2013 | β |
| Common obesity risk alleles in childhood attention-deficit/hyperactivity disorder. | Albayrak Γ et al. | β | 2013 | β |
| Copy number variants in the kallikrein gene cluster. | Lindahl P et al. | β | 2013 | β |
| Copy number variation at 22q11.2: from rare variants to common mechanisms of developmental neuropsychiatric disorders. | Hiroi N et al. | β | 2013 | β |
| Dances with black widow spiders: dysregulation of glutamate signalling enters centre stage in ADHD. | Lesch KP et al. | β | 2013 | β |
| Determination of genomic copy number alteration emphasizing a restriction site-based strategy of genome re-sequencing. | Zheng C et al. | β | 2013 | β |
| Functional properties of rare missense variants of human CDH13 found in adult attention deficit/hyperactivity disorder (ADHD) patients. | Mavroconstanti T et al. | β | 2013 | β |
| Genetic causes of developmental disorders. | Vorstman JA et al. | β | 2013 | β |
| Genetics of attention-deficit/hyperactivity disorder: current findings and future directions. | Akutagava-Martins GC et al. | β | 2013 | β |
| GStream: improving SNP and CNV coverage on genome-wide association studies. | Alonso A et al. | β | 2013 | β |
| Is there a role for endogenous retroviruses to mediate long-term adaptive phenotypic response upon environmental inputs? | Sharif J et al. | β | 2013 | β |
| No association between general cognitive ability and rare copy number variation. | McRae AF et al. | β | 2013 | β |
| ParseCNV integrative copy number variation association software with quality tracking. | Glessner JT et al. | β | 2013 | β |
| Phenotypic impact of genomic structural variation: insights from and for human disease. | Weischenfeldt J et al. | β | 2013 | β |
| Polygenic transmission and complex neuro developmental network for attention deficit hyperactivity disorder: genome-wide association study of both common and rare variants. | Yang L et al. | β | 2013 | β |
| Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy. | Lal D et al. | β | 2013 | β |
| Rare genomic structural variants in complex disease: lessons from the replication of associations with obesity. | Walters RG et al. | β | 2013 | β |
| RBFOX1 and RBFOX3 mutations in rolandic epilepsy. | Lal D et al. | β | 2013 | β |
| The comorbidity of ADHD and autism spectrum disorder. | Antshel KM et al. | β | 2013 | β |
| The role of rs2237781 within GRM8 in eating behavior. | Gast MT et al. | β | 2013 | β |
| ADHD and autism: differential diagnosis or overlapping traits? A selective review. | Taurines R et al. | β | 2012 | β |
| A role of genomic copy number variation in the complex behavioral phenotype of alcohol dependence: a commentary. | Urban AE | β | 2012 | β |
| Attention-deficit/hyperactivity disorder genomics: update for clinicians. | Elia J et al. | β | 2012 | β |
| CNVs: harbingers of a rare variant revolution in psychiatric genetics. | Malhotra D et al. | β | 2012 | β |
| Confluence of genes, environment, development, and behavior in a post Genome-Wide Association Study world. | Vrieze SI et al. | β | 2012 | β |
| Copy-number disorders are a common cause of congenital kidney malformations. | Sanna-Cherchi S et al. | β | 2012 | β |
| De novo mutations in neurological and psychiatric disorders: effects, diagnosis and prevention. | Gauthier J et al. | β | 2012 | β |
| Developmental psychopathology: the role of structural variation in the genome. | Gill M | β | 2012 | β |
| Folate metabolism gene 5,10-methylenetetrahydrofolate reductase (MTHFR) is associated with ADHD in myelomeningocele patients. | Spellicy CJ et al. | β | 2012 | β |
| Genetics and hypertension: is it time to change my practice? | Delles C et al. | β | 2012 | β |
| Next-generation treatments for mental disorders. | Insel TR | β | 2012 | β |
| Phasing of many thousands of genotyped samples. | Williams AL et al. | β | 2012 | β |
| Serotonin in the modulation of neural plasticity and networks: implications for neurodevelopmental disorders. | Lesch KP et al. | β | 2012 | β |
| Small rare recurrent deletions and reciprocal duplications in 2q21.1, including brain-specific ARHGEF4 and GPR148. | Dharmadhikari AV et al. | β | 2012 | β |
| TNiK is required for postsynaptic and nuclear signaling pathways and cognitive function. | Coba MP et al. | β | 2012 | β |
| Transient mGlu5R inhibition enhances the survival of granule cell precursors in the neonatal cerebellum. | Kubera C et al. | β | 2012 | β |
| Early developmental cues for diagnosis of attention deficit/hyperactivity disorder in young children. | Berger I et al. | β | 2011 | β |